Back to trial detailsIntake questionnaire
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Applying to NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center · New York, New York
Answer a few short questions to share with the research team.
0 of 3 answered